Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels.

In conclusion, naringenin was found to have direct or indirect blocking activity on voltage-gated sodium channels encoded by the SCN9A gene. PMID: 29990870 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29990870?dopt=Abstract

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - July 6, 2018 Category: Drugs & Pharmacology Authors: Gumushan Aktas H, Akgun T Tags: Biomed Pharmacother Source Type: research